Menu

Member

133 posts

Posts (133)

Member SYRS 3 years ago #11

Low volume great sign. Everyone holding positions for huge announcement. Great data printout with an acquisition announcement

Member SYRS 3 years ago #12

Very common for the market to initially react negative to any significant change. The new CEO is a huge win for Syros. It was time for a new vision and direction. Best to make the move prior to a positive printout. Rumors of an acquisition make sense.

Member SYRS 3 years ago #13

I heard SYRS is being acquired. Anyone know at what price? I read between $15 to $25 dollars PS. Please assist. Thanks.

Member SYRS 3 years ago #14

SYRS will hit 15 to 20 dollars per share by Sept with the data printout.

Member SYRS 3 years ago #15

That’s a lie. Syros does not receive 3 million a year from Pfizer. Beware of shorter posts.

Member SYRS 3 years ago #16

Management needs to step up. We’ve allowed them to collect exuberant salaries and all they’ve done is ignored the original shareholders. Is it time to initiate a shareholder advocacy group? Very frustrated by their lack of caring. They claim to care about patients while lining their pockets. Maybe it’s time to engage a counter offensive. Or management should work to get the company acquired or engage new leadership that knows how to advance a company and it’s value.

Member SYRS 3 years ago #17

The markets need to stabilize. Zero leadership from DC.

Member SYRS 3 years ago #18

2023 the year of biotech acquisitions. Seen this before where a large pharma presses a stock price down before making a bid to buy.

Member SYRS 3 years ago #19

Bert and I are buying.

Member SYRS 3 years ago #20

SYRS$ next data printout will put them at a whole new level of valuation. Coming soon in 2023.